112 related articles for article (PubMed ID: 12200597)
1. Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study.
Yasuda M; Takesue F; Inutsuka S; Honda M; Nozoe T; Korenaga D
J Cancer Res Clin Oncol; 2002 Aug; 128(8):412-6. PubMed ID: 12200597
[TBL] [Abstract][Full Text] [Related]
2. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication.
Begnami MD; Fregnani JH; Nonogaki S; Soares FA
Hum Pathol; 2010 Aug; 41(8):1120-7. PubMed ID: 20334896
[TBL] [Abstract][Full Text] [Related]
5. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
[TBL] [Abstract][Full Text] [Related]
6. Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes.
Li JQ; Kubo A; Wu F; Usuki H; Fujita J; Bandoh S; Masaki T; Saoo K; Takeuchi H; Kobayashi S; Imaida K; Maeta H; Ishida T; Kuriyama S
Int J Oncol; 2003 May; 22(5):1101-10. PubMed ID: 12684677
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
Soria JC; Jang SJ; Khuri FR; Hassan K; Liu D; Hong WK; Mao L
Cancer Res; 2000 Aug; 60(15):4000-4. PubMed ID: 10945597
[TBL] [Abstract][Full Text] [Related]
8. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.
Nozoe T; Korenaga D; Kabashima A; Ohga T; Saeki H; Sugimachi K
Clin Cancer Res; 2002 Mar; 8(3):817-22. PubMed ID: 11895914
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of cyclin B1 in non-small cell lung cancer.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Kimura Y; Uchida Y
Oncol Rep; 2003; 10(5):1381-6. PubMed ID: 12883711
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
12. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
[TBL] [Abstract][Full Text] [Related]
13. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
[TBL] [Abstract][Full Text] [Related]
17. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma.
Harada H; Omura K; Nakajima Y; Hasegawa S; Mogi S
J Exp Clin Cancer Res; 2006 Sep; 25(3):351-6. PubMed ID: 17167975
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue.
Hassan KA; El-Naggar AK; Soria JC; Liu D; Hong WK; Mao L
Clin Cancer Res; 2001 Aug; 7(8):2458-62. PubMed ID: 11489826
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cyclin B1 protein expression in colorectal cancer.
Grabsch H; Lickvers K; Hansen O; Takeno S; Willers R; Stock W; Gabbert HE; Mueller W
Am J Clin Pathol; 2004 Oct; 122(4):511-6. PubMed ID: 15487447
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotype.
Yamashita H; Kitayama J; Ishikawa M; Nagawa H
J Surg Oncol; 2007 Mar; 95(4):324-31. PubMed ID: 17066404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]